Developer docs
API playgroundTry for free, no card

Search company profiles

BaseClear

Full company profile

uuid000lnxr

Namestring
BaseClear
Legal namestring
BaseClear B.V.
Websiteurl
baseclear.com
Company typeenum
Private
Founded yearint
1993
Descriptiontext

BaseClear B.V. is a Dutch contract research laboratory specializing in microbial genomics and DNA-based analysis, founded in 1993 and headquartered in Leiden, Netherlands, with additional sites on Galileiweg and a PO Box address in the same city. The company serves enterprise clients in pharmaceutical, food and beverage, personal care, animal health, and academic research with a portfolio built around three service pillars: sequencing (Illumina, Oxford Nanopore, Sanger, whole genome), microbiome analysis and bioinformatics (metagenomics, amplicon profiling, metatranscriptomics, pathogen detection, biomarker discovery), and regulatory affairs and microbiology (strain discovery, safety assessment, EFSA compliance dossiers). GMP-certified testing is delivered through its wholly-owned ProBase Pharma subsidiary, and the company also distributes Zymo Research, Base-Gene, and Kisker Biotech products in Europe.

Technically, BaseClear integrates multiple sequencing platforms with proprietary bioinformatics pipelines, including a shallow-shotgun Infant Microbiome Pipeline with a customized database (Kraken 2/Bracken), low-biomass sample handling using proprietary qPCR-based QC, an AMR gene screening pipeline (CARD/VFDB), and a 2025-launched ML-powered Key Microbiome Pipeline for biomarker discovery using ensemble learning. The team comprises 65+ PhD-level molecular biologists, microbiome specialists, and bioinformatics experts, and the company maintains a 30-year proprietary knowledge base in microbial genomics.

Commercially, BaseClear operates a project-based professional services model priced in euros (orders up to €5,000 invoiced in full on acceptance; orders of €5,000+ require 50% upfront with the balance invoiced after draft report, net 14 days). Go-to-market is sales-led and event-driven: direct enterprise engagement through an online ordering portal and request-quotation workflow, supported by recurring Experts Meetings, webinars, scientific content, and conferences. Named customers include Abbott Biologicals, DSM, Reckitt Benckiser, Danone, IFF, Lesaffre, Jennewein Biotechnologie, CHDR, and Wageningen University. The company is privately held (B.V.), with no disclosed external funding or M&A activity.

Short descriptiontext

BaseClear is a Dutch contract research laboratory specializing in microbial genomics and DNA-based analysis, serving enterprise clients in pharmaceutical, food and beverage, personal care, animal health, and academic research sectors since 1993.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLeiden, Netherlands
HQ citystring
Leiden
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbial genomics services, DNA sequencing services, microbiome analysis, next-generation sequencing, contract research laboratory
Industry3 codes
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Laboratory Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Laboratory Services - Sequencing
TypeProfessional Services
Description

BaseClear provides comprehensive sequencing services including Next-Generation Sequencing (Illumina, Nanopore), Whole Genome Sequencing, and Sanger sequencing. These services are delivered as project-based engagements with GMP and non-GMP options.

baseclear.com
2Microbiome Analysis & Bioinformatics
TypeProfessional Services
Description

Turnkey microbiome analysis services including study design consultancy, sampling solutions, DNA/RNA extraction, sequencing, and downstream bioinformatics and biostatistical analysis. Delivered as project-based professional services.

baseclear.com
3Regulatory Affairs & Microbiology
TypeProfessional Services
Description

Regulatory affairs services including GMM dossier preparation, novel food applications, EFSA compliance, and safety assessment dossiers. Microbiology services include strain discovery, safety assessment, and product IP & regulatory scoping.

baseclear.com
4Microbial Identification & Quality Testing
TypeProfessional Services
Description

Rapid microbial identification services using MicroSEQ and MALDI-TOF, microbial strain typing, cell line characterization, mycoplasma detection, and adventitious agents testing. GMP-certified options available for pharmaceutical quality control.

baseclear.com
5Lab Products Distribution
TypeHardware Sales
Description

Distribution of third-party lab products including Zymo Research (sample collection, DNA/RNA purification, epigenetics, microbiomics), Base-Gene, and Kisker Biotech products.

baseclear.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Project-based laboratory services
ModelOtherBilling cadencePay-as-you-go
Notes

Orders up to €5,000 are invoiced for the full amount upon quotation acceptance. Orders of €5,000 and above require 50% down payment with remaining 50% invoiced after draft report submission. Prices in euros excluding VAT. Payment term: 14 days.

baseclear.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BaseClear is a contract research laboratory specializing in microbial genomics and DNA-based analysis. The company delivers sequencing services (Illumina, Nanopore, Sanger, whole genome), comprehensive microbiome analysis with bioinformatics, microbial identification and quality control testing, and regulatory affairs support covering safety assessment and EFSA/FDA/EMA compliance for food, pharmaceutical, personal care, and animal health clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Delivery time of 1-3 working days for microbial identification using MALDI-TOF
+4 more records
Product overview1 text field

BaseClear is a microbial genomics contract research organization established in 1993, offering a comprehensive portfolio of laboratory services organized around three core pillars: (1) Sequencing Services covering Illumina and Nanopore next-generation sequencing, whole genome sequencing, and Sanger sequencing; (2) Microbiome Analysis & Bioinformatics including shotgun metagenomics, amplicon profiling, metatranscriptomics, and the newly launched ML-powered Key Microbiome Pipeline for biomarker discovery; and (3) Regulatory Affairs & Microbiology providing safety assessments, strain discovery, and EFSA compliance support. The company also operates ProBase Pharma as its GMP-certified brand for rapid molecular testing and quality control. Additional offerings include distributed lab products from Zymo Research, Base-Gene, and Kisker Biotech. Results are delivered through BaseClear's proprietary Genome Explorer online portal.

Product and service15 records
1Next-Generation Sequencing Services
CategorySequencing Services
Description

Illumina and Nanopore next-generation sequencing services for microbial genomics applications, including real-time qPCR services, targeted at pharma, food, personal care, and academic clients requiring high-resolution microbial DNA analysis.

2Whole Genome Sequencing
CategorySequencing Services
Description

Complete microbial genome sequencing service providing finished genome assemblies for bacteria, yeast, and other microorganisms for research and industrial clients.

3Sanger Sequencing
CategorySequencing Services
Description

Traditional capillary DNA sequencing for validation, verification, and confirmation of genetic material, including plasmid/viral vector verification and cell line identity confirmation.

4ProBase Pharma (GMP Sequencing & Quality Control)
CategoryGMP Quality Control Services
Description

GMP-certified DNA-based quality control testing for raw materials, process intermediates, and finished products in food and pharmaceutical industries, offered under the ProBase Pharma brand.

5Microbiome Analysis & Bioinformatics
CategoryMicrobiome Analysis Services
Description

Comprehensive microbiome analysis including shotgun metagenomics, 16S/ITS amplicon profiling, (meta)transcriptomics, pathogen detection, comparative genomics, RNA-seq analysis, and key microbial biomarker detection with interactive data visualization through the Genome Explorer portal.

6Infant Microbiome Pipeline
CategoryMicrobiome Analysis Services
Description

Specialized shallow shotgun sequencing pipeline with a customized infant microbiome database providing strain-level abundance profiles across multiple microbial kingdoms (bacteria, fungi, archaea, viruses) for infant nutrition and health research clients.

7Key Microbiome Pipeline (ML-powered Biomarker Discovery)
CategoryMicrobiome Analysis Services
Description

Machine learning-powered bioinformatics service for identifying microbial biomarkers linked to disease states or treatment responses in clinical trials, using ensemble ML frameworks combining support vector machines, random forest classifiers, and clustering algorithms.

8Microbial Identification Services
CategoryMicrobial Identification Services
Description

Rapid molecular identification of bacteria and fungi using qPCR, DNA sequencing, and MALDI-TOF technology, including the FDA- and EMA-endorsed MicroSEQ system, with results delivered in 1-3 working days.

9Regulatory Affairs & Microbiology Services
CategoryRegulatory Affairs Services
Description

Comprehensive regulatory support including novel strain discovery, safety assessment, product IP scoping, EFSA compliance dossier preparation, GMM dossier preparation, novel food applications, and antimicrobial susceptibility (MIC) testing.

10Antimicrobial Resistance (AMR) Analysis
CategorySpecialized Application Services
Description

Whole-genome shotgun metagenomics pipeline for characterizing antibiotic resistance genes using CARD and VFDB databases, with EFSA AMR compliance testing including WGS-based AMR gene screening, MIC testing, and antimicrobial production analysis.

11Human Gut Microbiome Analysis
CategorySpecialized Application Services
Description

Complete gut microbiome analysis including sampling logistics, DNA/RNA extraction, shotgun metagenomics, and biostatistical analysis for clinical trials, probiotic development, and human health research.

12Skin Microbiome Analysis
CategorySpecialized Application Services
Description

Species-level taxonomic profiling for skin and low-biomass samples using shotgun metagenomics with proprietary qPCR-based QC assessment, supporting personal care product development and microbiome-friendly claims.

13Animal Microbiome Analysis
CategorySpecialized Application Services
Description

Complete microbiome analysis services for various animal species including swine, poultry, aquaculture, and ruminants, covering feed efficiency, gut health, antimicrobial resistance monitoring, and probiotic development.

14Methane Metabolism & Antimicrobial Screening
CategorySpecialized Application Services
Description

In-house methane metabolism pipeline for analyzing gut microbiome function and screening for antimicrobial compounds, particularly relevant to ruminant agriculture and climate research.

15Lab Products Distribution (Zymo Research, Base-Gene, Kisker Biotech)
CategoryLab Products Distribution
Description

Authorized European distribution of Zymo Research products (sample collection, DNA/RNA purification, epigenetics, microbiomics), Base-Gene, and Kisker Biotech laboratory products.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-05-14
Description

Dr. Kaouther Ben Amor, Senior Team Leader Probiotics at Danone, spoke at BaseClear's Infant & Pregnancy Microbiome Experts Meeting. Danone conducted clinical trials on C-section infant microbiome restoration using pre- and probiotic mixtures.

Strategic tierCoreTypeTechnology or Integration
Description

Collaborative partnership to scale Oxford Nanopore sequencing capacity for microbial insights. BaseClear worked with Oxford Nanopore to develop future-ready long-read sequencing services supporting advanced microbial discovery for complex projects like soil metagenomics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHDR collaborates with BaseClear for skin and gut microbiome analysis in clinical trials. BaseClear is involved from project application through study design, providing technical, scientific, and logistical support. Partnership includes sampling logistics with barcode-labeled tubes and bioinformatics collaboration.

4DSM Nutritional Products
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration between BaseClear and DSM scientists to advance sequencing technologies and microbiome research. Dr. Riccardo Sfriso from DSM participated in interviews on skin microbiome trends, and BaseClear provides state-of-the-art microbiome analyses for DSM's personal care product development.

baseclear.com
5ARTIS Micropia
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

BaseClear partnered with Micropia ARTIS on the 'Primate Rewilding Project' to understand and identify primate gut microbiome, carbohydrate pathway analysis, and link to high-fibre natural diet. BaseClear led the genomics perspective including study design, sampling collection, and analysis.

baseclear.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Prof. Remco Kort from Vrije University on the Primate Rewilding Project. Vrije University provided the foundational database for primate gut microbial genomics that BaseClear built upon.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BaseClear is an authorized distributor of Zymo Research products in Europe, offering sample collection & preservation, DNA/RNA purification, epigenetics, microbiomics, E.coli, and yeast products.

8Base-Gene
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

BaseClear offers Base-Gene products as part of their lab product offerings.

baseclear.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

BaseClear distributes Kisker Biotech products as part of their lab product portfolio.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Maciej Chichlowski from Reckitt Benckiser participated in expert meeting on infant microbiome hosted by BaseClear. Discussion focused on role of nutrition in infant microbiome development and collaboration on preclinical studies involving microbiome in pediatric nutrition.

11Jennewein Biotechnologie
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Katja Parschat from Jennewein spoke at BaseClear's expert meeting on Human Milk Oligosaccharides (HMOs) as functional food ingredients. Active in infant nutrition and microbiome research collaboration.

baseclear.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Clara Belzer from Wageningen University presented at BaseClear's expert meeting. Academic collaboration on microbiome research including gut-brain axis and early infant microbiome development.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Katri Korpela from University of Helsinki presented research on effects of birth mode and antibiotics on mother-infant microbiome at BaseClear's expert meeting.

14UMCG (University Medical Center Groningen)
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Marijke Faas from UMCG presented research on gut microbiome and immune changes during pregnancy at BaseClear's expert meeting.

baseclear.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Steve James from Quadram Institute Biosciences presented on infant gut mycobiome at BaseClear's expert meeting on infant and pregnancy microbiome.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Maciej Chichlowski from RB/Mead Johnson Nutrition presented on 'healthy' gut microbiome at BaseClear's expert meeting. Active collaboration on infant nutrition and microbiome research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CosmosID provides commercial microbiome analytics services using proprietary sequencing-based microbial identification and bioinformatics pipelines. It directly competes with BaseClear in shotgun metagenomics, AMR gene screening, and microbiome bioinformatics for pharmaceutical, food, and consumer health customers.

2Diversigen (OraSure Technologies)
TypeDirect peer
Description

Diversigen is a US-based microbiome services provider offering 16S, shotgun metagenomics, and bioinformatics for pharma, nutrition, and academic clients. It is a direct competitor to BaseClear's microbiome analysis pipeline, with overlapping technology stack and target customers.

TypeDirect peer
Description

Microsynth is a European (Switzerland/Germany/Austria) contract genomics provider offering Sanger, NGS, and custom sequencing services. It competes with BaseClear for European biotech and academic sequencing projects with similar turnaround expectations and service-level positioning.

TypeBroad incumbent
Description

QIAGEN offers genomic services and bioinformatics tools for microbial typing, microbiome analysis, and pharmaceutical QC. It competes with BaseClear's microbial identification and metagenomics work while also supplying the underlying sample-prep and analysis tools used by many microbiome researchers.

TypeBroad incumbent
Description

Eurofins Genomics is the sequencing services arm of Eurofins Scientific, one of the world's largest testing services groups. It offers Sanger, NGS, and synthesis services globally, overlapping with BaseClear's sequencing portfolio while operating at substantially larger scale across multiple service lines beyond microbial genomics.

TypeBroad incumbent
Description

LGC Group operates a genomics division offering Sanger, NGS, and genotyping services alongside its standards and measurement science business. It competes with BaseClear for European sequencing and microbial identification work, particularly in regulated industries.

TypeEmerging player
Description

Zymo Research manufactures sample collection, DNA/RNA purification, and microbiome kits, and is a key supplier whose products BaseClear distributes in Europe. Zymo is also expanding into service offerings, making it both a partner and an emerging competitor in microbiome analysis services.

TypeBroad incumbent
Description

Charles River Laboratories is a large preclinical CRO offering microbial identification, cell line characterization, and GMP testing services. Its microbial solutions overlap with BaseClear's ProBase Pharma GMP offerings while serving broader biopharmaceutical development needs.

9Second Genome (now part of Pfizer)
TypeEmerging player
Description

Second Genome is a microbiome drug discovery and services company using metagenomics and bioinformatics to identify therapeutic targets. It overlaps with BaseClear's ML biomarker discovery and clinical trial microbiome services, particularly for pharma-sponsored studies.

TypeDirect peer
Description

MR DNA is a US-based molecular research lab specializing in 16S, shotgun metagenomics, and environmental microbiome sequencing. It is a direct competitor to BaseClear's microbiome services, particularly for agricultural, environmental, and animal health microbiome projects.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BaseClear

Contract Research Laboratory Servicesbaseclear.com

BaseClear is a Dutch contract research laboratory specializing in microbial genomics and DNA-based analysis, serving enterprise clients in pharmaceutical, food and beverage, personal care, animal health, and academic research sectors since 1993.

What BaseClear does

BaseClear B.V. is a Dutch contract research laboratory specializing in microbial genomics and DNA-based analysis, founded in 1993 and headquartered in Leiden, Netherlands, with additional sites on Galileiweg and a PO Box address in the same city. The company serves enterprise clients in pharmaceutical, food and beverage, personal care, animal health, and academic research with a portfolio built around three service pillars: sequencing (Illumina, Oxford Nanopore, Sanger, whole genome), microbiome analysis and bioinformatics (metagenomics, amplicon profiling, metatranscriptomics, pathogen detection, biomarker discovery), and regulatory affairs and microbiology (strain discovery, safety assessment, EFSA compliance dossiers). GMP-certified testing is delivered through its wholly-owned ProBase Pharma subsidiary, and the company also distributes Zymo Research, Base-Gene, and Kisker Biotech products in Europe.

Technically, BaseClear integrates multiple sequencing platforms with proprietary bioinformatics pipelines, including a shallow-shotgun Infant Microbiome Pipeline with a customized database (Kraken 2/Bracken), low-biomass sample handling using proprietary qPCR-based QC, an AMR gene screening pipeline (CARD/VFDB), and a 2025-launched ML-powered Key Microbiome Pipeline for biomarker discovery using ensemble learning. The team comprises 65+ PhD-level molecular biologists, microbiome specialists, and bioinformatics experts, and the company maintains a 30-year proprietary knowledge base in microbial genomics.

Commercially, BaseClear operates a project-based professional services model priced in euros (orders up to €5,000 invoiced in full on acceptance; orders of €5,000+ require 50% upfront with the balance invoiced after draft report, net 14 days). Go-to-market is sales-led and event-driven: direct enterprise engagement through an online ordering portal and request-quotation workflow, supported by recurring Experts Meetings, webinars, scientific content, and conferences. Named customers include Abbott Biologicals, DSM, Reckitt Benckiser, Danone, IFF, Lesaffre, Jennewein Biotechnologie, CHDR, and Wageningen University. The company is privately held (B.V.), with no disclosed external funding or M&A activity.

BaseClear firmographics

Firmographics
Name
BaseClear
Legal name
BaseClear B.V.
Website
https://baseclear.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Short description
BaseClear is a Dutch contract research laboratory specializing in microbial genomics and DNA-based analysis, serving enterprise clients in pharmaceutical, food and beverage, personal care, animal health, and academic research sectors since 1993.
Ownership category
akta.pro rank

BaseClear industry classification

Industry
Product category
Contract Research Laboratory Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Keywords

  • Microbial genomics services
  • DNA sequencing services
  • Microbiome analysis
  • Next-generation sequencing
  • Contract research laboratory

Where BaseClear is headquartered

Location

Headquarters

HQ city
Leiden
HQ country
Netherlands
HQ region
Europe

Offices3 records

Markets served

BaseClear business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Laboratory Services - Sequencing: BaseClear provides comprehensive sequencing services including Next-Generation Sequencing (Illumina, Nanopore), Whole Genome Sequencing, and Sanger sequencing. These services are delivered as project-based engagements with GMP and non-GMP options.
  2. Microbiome Analysis & Bioinformatics: Turnkey microbiome analysis services including study design consultancy, sampling solutions, DNA/RNA extraction, sequencing, and downstream bioinformatics and biostatistical analysis. Delivered as project-based professional services.
  3. Regulatory Affairs & Microbiology: Regulatory affairs services including GMM dossier preparation, novel food applications, EFSA compliance, and safety assessment dossiers. Microbiology services include strain discovery, safety assessment, and product IP & regulatory scoping.
  4. Microbial Identification & Quality Testing: Rapid microbial identification services using MicroSEQ and MALDI-TOF, microbial strain typing, cell line characterization, mycoplasma detection, and adventitious agents testing. GMP-certified options available for pharmaceutical quality control.
  5. Lab Products Distribution: Distribution of third-party lab products including Zymo Research (sample collection, DNA/RNA purification, epigenetics, microbiomics), Base-Gene, and Kisker Biotech products.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goProject-based laboratory services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

BaseClear product offering

Product offering

Core offering

BaseClear is a contract research laboratory specializing in microbial genomics and DNA-based analysis. The company delivers sequencing services (Illumina, Nanopore, Sanger, whole genome), comprehensive microbiome analysis with bioinformatics, microbial identification and quality control testing, and regulatory affairs support covering safety assessment and EFSA/FDA/EMA compliance for food, pharmaceutical, personal care, and animal health clients.

Product overview

BaseClear is a microbial genomics contract research organization established in 1993, offering a comprehensive portfolio of laboratory services organized around three core pillars: (1) Sequencing Services covering Illumina and Nanopore next-generation sequencing, whole genome sequencing, and Sanger sequencing; (2) Microbiome Analysis & Bioinformatics including shotgun metagenomics, amplicon profiling, metatranscriptomics, and the newly launched ML-powered Key Microbiome Pipeline for biomarker discovery; and (3) Regulatory Affairs & Microbiology providing safety assessments, strain discovery, and EFSA compliance support. The company also operates ProBase Pharma as its GMP-certified brand for rapid molecular testing and quality control. Additional offerings include distributed lab products from Zymo Research, Base-Gene, and Kisker Biotech. Results are delivered through BaseClear's proprietary Genome Explorer online portal.

Differentiator

Problem solved

Functional benefit

Products and services

  • Next-Generation Sequencing Services Illumina and Nanopore next-generation sequencing services for microbial genomics applications, including real-time qPCR services, targeted at pharma, food, personal care, and academic clients requiring high-resolution microbial DNA analysis.
  • Whole Genome Sequencing Complete microbial genome sequencing service providing finished genome assemblies for bacteria, yeast, and other microorganisms for research and industrial clients.
  • Sanger Sequencing Traditional capillary DNA sequencing for validation, verification, and confirmation of genetic material, including plasmid/viral vector verification and cell line identity confirmation.
  • ProBase Pharma (GMP Sequencing & Quality Control) GMP-certified DNA-based quality control testing for raw materials, process intermediates, and finished products in food and pharmaceutical industries, offered under the ProBase Pharma brand.
  • Microbiome Analysis & Bioinformatics Comprehensive microbiome analysis including shotgun metagenomics, 16S/ITS amplicon profiling, (meta)transcriptomics, pathogen detection, comparative genomics, RNA-seq analysis, and key microbial biomarker detection with interactive data visualization through the Genome Explorer portal.
  • Infant Microbiome Pipeline Specialized shallow shotgun sequencing pipeline with a customized infant microbiome database providing strain-level abundance profiles across multiple microbial kingdoms (bacteria, fungi, archaea, viruses) for infant nutrition and health research clients.
  • Key Microbiome Pipeline (ML-powered Biomarker Discovery) Machine learning-powered bioinformatics service for identifying microbial biomarkers linked to disease states or treatment responses in clinical trials, using ensemble ML frameworks combining support vector machines, random forest classifiers, and clustering algorithms.
  • Microbial Identification Services Rapid molecular identification of bacteria and fungi using qPCR, DNA sequencing, and MALDI-TOF technology, including the FDA- and EMA-endorsed MicroSEQ system, with results delivered in 1-3 working days.
  • Regulatory Affairs & Microbiology Services Comprehensive regulatory support including novel strain discovery, safety assessment, product IP scoping, EFSA compliance dossier preparation, GMM dossier preparation, novel food applications, and antimicrobial susceptibility (MIC) testing.
  • Antimicrobial Resistance (AMR) Analysis Whole-genome shotgun metagenomics pipeline for characterizing antibiotic resistance genes using CARD and VFDB databases, with EFSA AMR compliance testing including WGS-based AMR gene screening, MIC testing, and antimicrobial production analysis.
  • Human Gut Microbiome Analysis Complete gut microbiome analysis including sampling logistics, DNA/RNA extraction, shotgun metagenomics, and biostatistical analysis for clinical trials, probiotic development, and human health research.
  • Skin Microbiome Analysis Species-level taxonomic profiling for skin and low-biomass samples using shotgun metagenomics with proprietary qPCR-based QC assessment, supporting personal care product development and microbiome-friendly claims.
  • Animal Microbiome Analysis Complete microbiome analysis services for various animal species including swine, poultry, aquaculture, and ruminants, covering feed efficiency, gut health, antimicrobial resistance monitoring, and probiotic development.
  • Methane Metabolism & Antimicrobial Screening In-house methane metabolism pipeline for analyzing gut microbiome function and screening for antimicrobial compounds, particularly relevant to ruminant agriculture and climate research.
  • Lab Products Distribution (Zymo Research, Base-Gene, Kisker Biotech) Authorized European distribution of Zymo Research products (sample collection, DNA/RNA purification, epigenetics, microbiomics), Base-Gene, and Kisker Biotech laboratory products.

Quantifiable outcome

  • Delivery time of 1-3 working days for microbial identification using MALDI-TOF
  • +4 more outcomes

Companies that use BaseClear

Customer profile

Named customers11 records

Segments8 records

Ideal customer profiles4 records

BaseClear technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

BaseClear partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, strategic and minor.

  • DanonecoreStrategic or Co-development Partner · 14 May 2020Dr. Kaouther Ben Amor, Senior Team Leader Probiotics at Danone, spoke at BaseClear's Infant & Pregnancy Microbiome Experts Meeting. Danone conducted clinical trials on C-section infant microbiome restoration using pre- and probiotic mixtures.
  • Oxford Nanopore TechnologiescoreTechnology or IntegrationCollaborative partnership to scale Oxford Nanopore sequencing capacity for microbial insights. BaseClear worked with Oxford Nanopore to develop future-ready long-read sequencing services supporting advanced microbial discovery for complex projects like soil metagenomics.
  • Center for Human Drug Research (CHDR)coreStrategic or Co-development PartnerCHDR collaborates with BaseClear for skin and gut microbiome analysis in clinical trials. BaseClear is involved from project application through study design, providing technical, scientific, and logistical support. Partnership includes sampling logistics with barcode-labeled tubes and bioinformatics collaboration.
  • DSM Nutritional ProductscoreStrategic or Co-development PartnerCollaboration between BaseClear and DSM scientists to advance sequencing technologies and microbiome research. Dr. Riccardo Sfriso from DSM participated in interviews on skin microbiome trends, and BaseClear provides state-of-the-art microbiome analyses for DSM's personal care product development.
  • ARTIS MicropiastrategicStrategic or Co-development PartnerBaseClear partnered with Micropia ARTIS on the 'Primate Rewilding Project' to understand and identify primate gut microbiome, carbohydrate pathway analysis, and link to high-fibre natural diet. BaseClear led the genomics perspective including study design, sampling collection, and analysis.
  • Vrije UniversitystrategicStrategic or Co-development PartnerPartnership with Prof. Remco Kort from Vrije University on the Primate Rewilding Project. Vrije University provided the foundational database for primate gut microbial genomics that BaseClear built upon.
  • Zymo ResearchcoreChannel Partner/ Reseller/ DistributorBaseClear is an authorized distributor of Zymo Research products in Europe, offering sample collection & preservation, DNA/RNA purification, epigenetics, microbiomics, E.coli, and yeast products.
  • Base-GeneminorChannel Partner/ Reseller/ DistributorBaseClear offers Base-Gene products as part of their lab product offerings.
  • Kisker BiotechminorChannel Partner/ Reseller/ DistributorBaseClear distributes Kisker Biotech products as part of their lab product portfolio.
  • Reckitt BenckisercoreStrategic or Co-development PartnerDr. Maciej Chichlowski from Reckitt Benckiser participated in expert meeting on infant microbiome hosted by BaseClear. Discussion focused on role of nutrition in infant microbiome development and collaboration on preclinical studies involving microbiome in pediatric nutrition.
  • Jennewein BiotechnologiestrategicStrategic or Co-development PartnerDr. Katja Parschat from Jennewein spoke at BaseClear's expert meeting on Human Milk Oligosaccharides (HMOs) as functional food ingredients. Active in infant nutrition and microbiome research collaboration.
  • Wageningen UniversitystrategicStrategic or Co-development PartnerDr. Clara Belzer from Wageningen University presented at BaseClear's expert meeting. Academic collaboration on microbiome research including gut-brain axis and early infant microbiome development.
  • University of HelsinkistrategicStrategic or Co-development PartnerDr. Katri Korpela from University of Helsinki presented research on effects of birth mode and antibiotics on mother-infant microbiome at BaseClear's expert meeting.
  • UMCG (University Medical Center Groningen)strategicStrategic or Co-development PartnerDr. Marijke Faas from UMCG presented research on gut microbiome and immune changes during pregnancy at BaseClear's expert meeting.
  • Quadram Institute BiosciencesstrategicStrategic or Co-development PartnerDr. Steve James from Quadram Institute Biosciences presented on infant gut mycobiome at BaseClear's expert meeting on infant and pregnancy microbiome.
  • RB/Mead Johnson NutritioncoreStrategic or Co-development PartnerDr. Maciej Chichlowski from RB/Mead Johnson Nutrition presented on 'healthy' gut microbiome at BaseClear's expert meeting. Active collaboration on infant nutrition and microbiome research.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

BaseClear competitors and assessment

Company assessment

Direct peers

  • CosmosID: CosmosID provides commercial microbiome analytics services using proprietary sequencing-based microbial identification and bioinformatics pipelines. It directly competes with BaseClear in shotgun metagenomics, AMR gene screening, and microbiome bioinformatics for pharmaceutical, food, and consumer health customers.
  • Diversigen (OraSure Technologies): Diversigen is a US-based microbiome services provider offering 16S, shotgun metagenomics, and bioinformatics for pharma, nutrition, and academic clients. It is a direct competitor to BaseClear's microbiome analysis pipeline, with overlapping technology stack and target customers.
  • Microsynth: Microsynth is a European (Switzerland/Germany/Austria) contract genomics provider offering Sanger, NGS, and custom sequencing services. It competes with BaseClear for European biotech and academic sequencing projects with similar turnaround expectations and service-level positioning.
  • MR DNA (Molecular Research LP): MR DNA is a US-based molecular research lab specializing in 16S, shotgun metagenomics, and environmental microbiome sequencing. It is a direct competitor to BaseClear's microbiome services, particularly for agricultural, environmental, and animal health microbiome projects.

Broad incumbents

  • QIAGEN (Genomics Services): QIAGEN offers genomic services and bioinformatics tools for microbial typing, microbiome analysis, and pharmaceutical QC. It competes with BaseClear's microbial identification and metagenomics work while also supplying the underlying sample-prep and analysis tools used by many microbiome researchers.
  • Eurofins Genomics: Eurofins Genomics is the sequencing services arm of Eurofins Scientific, one of the world's largest testing services groups. It offers Sanger, NGS, and synthesis services globally, overlapping with BaseClear's sequencing portfolio while operating at substantially larger scale across multiple service lines beyond microbial genomics.
  • LGC Group (Genomics Division): LGC Group operates a genomics division offering Sanger, NGS, and genotyping services alongside its standards and measurement science business. It competes with BaseClear for European sequencing and microbial identification work, particularly in regulated industries.
  • Charles River Laboratories: Charles River Laboratories is a large preclinical CRO offering microbial identification, cell line characterization, and GMP testing services. Its microbial solutions overlap with BaseClear's ProBase Pharma GMP offerings while serving broader biopharmaceutical development needs.

Emerging players

  • Zymo Research: Zymo Research manufactures sample collection, DNA/RNA purification, and microbiome kits, and is a key supplier whose products BaseClear distributes in Europe. Zymo is also expanding into service offerings, making it both a partner and an emerging competitor in microbiome analysis services.
  • Second Genome (now part of Pfizer): Second Genome is a microbiome drug discovery and services company using metagenomics and bioinformatics to identify therapeutic targets. It overlaps with BaseClear's ML biomarker discovery and clinical trial microbiome services, particularly for pharma-sponsored studies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BaseClear social profiles

Digital presence

BaseClear compliance and trust

Trust signal

Compliance3 records

BaseClear financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BaseClear leadership team

Management profile

Number of profiles

Profiles10 records

BaseClear subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BaseClear funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BaseClear M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BaseClear

What does BaseClear do?

BaseClear is a contract research laboratory specializing in microbial genomics and DNA-based analysis. The company delivers sequencing services (Illumina, Nanopore, Sanger, whole genome), comprehensive microbiome analysis with bioinformatics, microbial identification and quality control testing, and regulatory affairs support covering safety assessment and EFSA/FDA/EMA compliance for food, pharmaceutical, personal care, and animal health clients.

Is BaseClear a public or private company?

BaseClear is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BaseClear founded?

BaseClear was founded in 1993. It employs 51 to 100 people.

Where is BaseClear based?

BaseClear is headquartered in Leiden, Netherlands, in the Europe region.

How does BaseClear make money?

Five revenue lines are on record. Laboratory Services - Sequencing is the primary driver. The others are microbiome Analysis & Bioinformatics, regulatory Affairs & Microbiology, microbial Identification & Quality Testing and lab Products Distribution.

Who are BaseClear's main competitors?

Direct peers on record are CosmosID, Diversigen (OraSure Technologies), Microsynth and MR DNA (Molecular Research LP). Broad incumbents are QIAGEN (Genomics Services), Eurofins Genomics, LGC Group (Genomics Division) and Charles River Laboratories. Emerging players are Zymo Research and Second Genome (now part of Pfizer).

Does BaseClear have an API?

No public API is recorded for BaseClear.

What industry is BaseClear in?

BaseClear's product category is Contract Research Laboratory Services. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMicrobiome sequencing service Market Competitive Growth Analysis, Industry Size, Share, And Forecast 2032 | Baseclear B.V. (Netherlands), Zymo Research Corporation. (U.S.)The global microbiome sequencing services market was valued at USD 1.38 billion in 2024 and is projected to grow at a CAGR of 10.10% from 2024 to 2032. North America is expected to dominate due to favorable reimbursement policies, while Asia-Pacific is anticipated to see significant growth from healthcare infrastructure development.PR NewswireGlobal Long Read Sequencing Market Report to 2031 - Featuring Agilent Technologies, BaseClear, Cantata Bio and F. Hoffmann-La Roche Among OthersResearchAndMarkets has added a market forecast report for the global long-read sequencing sector, projecting the market value to grow from $603.48 million in 2021 to $4.5 billion by 2031 at a CAGR of 22.3%. The report identifies key industry drivers such as increased R&D investment and demand for genome mapping, alongside restraints like ethical limitations and lower read accuracy in nanopore technologies. It profiles major participants including Agilent Technologies, F. Hoffmann-La Roche, and Oxford Nanopore Technologies within a segmented analysis of techniques, products, and end-users.PR NewswireHuman Microbiome Industry Analysis, 2014-2024 - Increasing Collaboration Between Market Players and AcademiaResearchAndMarkets.com published a global human microbiome market report covering the 2014-2024 period, with the market valued at USD 351.81 million in 2018, segmented by product type, disease application, and regional markets. The report identifies North America as the largest regional market driven by favorable reimbursement policies and high healthcare awareness. The analysis includes market sizing, forecasts, competitive landscape, and strategic assessments for companies including OptiBiotix Health, Metabiomics, OSEL Inc., PureTech Health, 4D Pharma, Synlogic Inc., BaseClear BV, Rebiotix Inc., Ritter Pharmaceuticals, and Assembly Bioscience Inc.